ImmunoScape’s Deep Immunomics platform utilizes proprietary combinatorial barcoding technologies allowing discovery of rare, therapeutically relevant T cells and their T cell receptor (TCR). Our platform allows large scale T cell mining of patient samples while retaining extraordinarily high sensitivity, regularly detecting antigen-specific CD8 T cells at frequencies as low as 0.001%.